Major
Metformin × Prednisolone
Biguanides. Oral antihyperglycemic agents×Glucocorticoids
Mechanism
Prednisolone (a systemic glucocorticoid) suppresses muscle glucose uptake and stimulates hepatic gluconeogenesis – steroid-induced diabetes develops or existing type 2 diabetes decompensates. Metformin offsets part of the effect but not all.
Symptoms
Hyperglycaemia: thirst, polyuria, fatigue, rising fasting glucose and HbA1c. With high prednisolone doses: decompensation risk with ketoacidosis in type 1 diabetes.
Management
Monitor glucose 4 times daily during the first week of combination, then by self-monitoring. Increase metformin to maximum (2000–2500 mg/day) as needed. If decompensation occurs, add an α-glucosidase inhibitor, a GLP-1 receptor agonist, or temporary insulin.
Check the full regimen, not just this pair
Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.
Sources
- ADA: Standards of Care in Diabetes 2024 – pharmacologic approaches to glycemic treatment (2024)– Diabetes Care 2024;47(Suppl 1):S158-S178
- FDA: Glucophage (metformin hydrochloride) prescribing information (2017)